Market Overview

Drug Abuse Testing Market to Reach $11.83 Bn, Globally, by 2025 at 8.2% CAGR: Allied Market Research

Share:

PORTLAND, Oregon, Feb. 12, 2019 /PRNewswire/ -- Allied Market Research published a report, titled, "Drug Abuse Testing Market by Product & Services (Analyzers, Rapid Testing Devices, Consumables, and Laboratory Services), Sample Type (Urine, Oral Fluid, Breath, Hair, and Others), and End User (Workplaces & Schools, Criminal Justice Systems & Law Enforcement Agencies, Research Laboratories, and Hospitals): Global Opportunity Analysis and Industry Forecast, 2018–2025". The report offers a detailed analysis of changing market trends, competitive landscape, market size & estimations, top winning strategies, and key market players. According to the report, the global drug abuse testing market generated $6.24 billion in 2017 and is expected to reach $11.83 billion by 2025, registering a CAGR of 8.2% from 2018 to 2025.

Allied_Market_Research_Logo

Surge in awareness regarding drug abuse, stringent regulations regarding drug abuse, and development of innovative drug testing equipment facilitate the growth in the market. However, potential manipulation of drug screening tests and consideration of drug testing as a breach of privacy rights hinder the market growth. On the other hand, technological advancements and untapped potential in emerging economies such as Asia-Pacific and LAMEA create new opportunities in the market.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/112  

Rapid testing devices to growth the fastest

Rapid testing devices would register the fastest CAGR of 14.2% from 2018 to 2025, owing to its benefits such as accuracy in results in less time and advent of technologically advanced devices. However, laboratory services accounted for nearly three-fifth of the total market share in 2017 and is expected to maintain its dominance throughout the forecast period. This is due to increase in consumption of alcohol and drugs during office hours, compelling organizations to carry out tests. The research also analyzes consumables and analyzers.

Urine sample type to maintain its lion's share by 2025

Based on sample type, urine held the major market share in 2017, contributing to 86.16% of the total market share in 2017. This segment is expected to maintain its lion's share till 2025, owing to lesser cost of urine sample analysis, ease in availability of point of care tests, and presence of parent drugs and/or metabolites in high concentrations. However, the hair segment is expected to register the fastest growth rate with a CAGR 12.0% from 2018 to 2025, owing to advantages such as high resistance to evasion through adulteration or substitution of samples and wide window of detection. The research also analyzes oral fluid, breath, and others.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/112

North America to maintain its lead by 2025

North America contributed to more than half of the total market share in 2017 and is expected to maintain its lead till 2025. This is due to expansion of big giants into the region to cater to increase in demand for drug abuse testing devices and products. However, Asia-Pacific is expected to register the fastest growth with a CAGR of 9.7% from 2018 to 2025, owing to different initiatives taken by governments to curb abuse in various fields such as workplaces, sports, and others.

Key Market Players

Leading market players studied in the research include Drägerwerk AG & Co. KGAA, Hoffmann-La Roche AG, Abbott Laboratories, Siemens AG, Biorad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Quest Diagnostics Incorporated, and Express Diagnostics International Inc.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.

Similar Reports:

Drug-Device Combination Products Market – Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Aneurysmal Subarachnoid Hemorrhage Drugs Market – Global Opportunity Analysis and Industry Forecast, 2017 – 2023

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Cision View original content:http://www.prnewswire.com/news-releases/drug-abuse-testing-market-to-reach-11-83-bn-globally-by-2025-at-8-2-cagr-allied-market-research-300793864.html

SOURCE Allied Market Research

View Comments and Join the Discussion!